Atomaktin Capsule
PDF Leaflet Revision Date: 21 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ADHD in children, adolescents, and adults.
Dosage (summary)
Children <70 kg: 0.5 mg/kg/day; Adults: 40 mg initial, 80 mg maintenance.
Special Populations
- Hepatic impairment
- End-stage renal disease
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- MAOIs
- CYP2D6 inhibitors
- Salbutamol
Contraindications
- Hypersensitivity
- Uncontrolled hypertension
- Narrow angle glaucoma
- Severe cardiovascular disorders
Common side effects
- Headache
- Abdominal pain
- Decreased appetite
- Nausea
- Fatigue
Counselling Points
- Monitor for suicidal thoughts
- Avoid in severe cardiac conditions
- Use caution when driving or operating machinery
Serious warnings
- Increased risk of suicidal ideation in children and adolescents
- Cardiovascular effects
Important Disclaimer
The Atomaktin Capsule professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
